Tags : QMF149

Novartis Reports Results of QMF149 in P-III PALLADIUM Study for

Shots: The P-III PALLADIUM study involves assessing of QMF149 [indacaterol acetate + mometasone furoate (IND/MF)] vs mometasone furoate (MF) as monothx. in 2,216 asthma patients with medium or high dose ICS or low dose ICS/LABA use 3mos. prior to screening, a pre-bronchodilator FEV1 of ≥50%, >80% of the predicted normal value for the patient and […]Read More